Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.
Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Goldstone AP, Wilding J, Lah M, Shaikh MG, Littlejohn E, Abuzzahab MJ, Fleischman A, Hirano P, Yen K, Cowen NM, Bhatnagar A; C601/C602 Investigators. Miller JL, et al. Among authors: yen k. Obesity (Silver Spring). 2024 Feb;32(2):252-261. doi: 10.1002/oby.23928. Epub 2023 Nov 2. Obesity (Silver Spring). 2024. PMID: 37919617
Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
Strong TV, Miller JL, McCandless SE, Gevers E, Yanovski JA, Matesevac L, Bohonowych J, Ballal S, Yen K, Hirano P, Cowen NM, Bhatnagar A. Strong TV, et al. Among authors: yen k. J Neurodev Disord. 2024 Apr 26;16(1):22. doi: 10.1186/s11689-024-09536-x. J Neurodev Disord. 2024. PMID: 38671361 Free PMC article.
Refractive change at 5 years in the Toddler Aphakia and Pseudophakia Study (TAPS).
VanderVeen DK, Wilson E, Wang JY, Traboulsi MEI, Freedman SF, Plager DA, Yen KG, Weil NC, Loh AR, Morrison D, Anderson JS, Lambert SR, Bothun ED; Toddler Aphakia and Pseudophakia Study. VanderVeen DK, et al. Among authors: yen kg. Ophthalmology. 2024 Dec 16:S0161-6420(24)00791-7. doi: 10.1016/j.ophtha.2024.12.027. Online ahead of print. Ophthalmology. 2024. PMID: 39694279
Mitochondrial-derived microproteins: from discovery to function.
Yen K, Miller B, Kumagai H, Silverstein A, Cohen P. Yen K, et al. Trends Genet. 2024 Dec 16:S0168-9525(24)00292-0. doi: 10.1016/j.tig.2024.11.010. Online ahead of print. Trends Genet. 2024. PMID: 39690001 Free article. Review.
MOTS-c modulates skeletal muscle function by directly binding and activating CK2.
Kumagai H, Kim SJ, Miller B, Zempo H, Tanisawa K, Natsume T, Lee SH, Wan J, Leelaprachakul N, Kumagai ME, Ramirez R 2nd, Mehta HH, Cao K, Oh TJ, Wohlschlegel JA, Sha J, Nishida Y, Fuku N, Dobashi S, Miyamoto-Mikami E, Takaragawa M, Fuku M, Yoshihara T, Naito H, Kawakami R, Torii S, Midorikawa T, Oka K, Hara M, Iwasaka C, Yamada Y, Higaki Y, Tanaka K, Yen K, Cohen P. Kumagai H, et al. Among authors: yen k. iScience. 2024 Oct 19;27(11):111212. doi: 10.1016/j.isci.2024.111212. eCollection 2024 Nov 15. iScience. 2024. PMID: 39559755 Free PMC article.
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Weidinger S, Blauvelt A, Papp KA, Reich A, Lee CH, Worm M, Lynde C, Kataoka Y, Foley P, Wei X, Wong W, Solente AC, Weber C, Adelman S, Davey S, Hurbin F, Rynkiewicz N, Yen K, O'Malley JT, Bernigaud C. Weidinger S, et al. Among authors: yen k. J Allergy Clin Immunol. 2024 Nov 8:S0091-6749(24)01175-8. doi: 10.1016/j.jaci.2024.10.031. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39522654 Free article.
628 results